Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;58(7):1065-1071.
doi: 10.2967/jnumed.116.186759. Epub 2017 Mar 2.

Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials

Affiliations
Review

Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials

Joshua S Scheuermann et al. J Nucl Med. 2017 Jul.

Abstract

The National Cancer Institute developed the Centers for Quantitative Imaging Excellence (CQIE) initiative in 2010 to prequalify imaging facilities at all of the National Cancer Institute-designated comprehensive and clinical cancer centers for oncology trials using advanced imaging techniques, including PET. Here we review the CQIE PET/CT scanner qualification process and results in detail. Methods: Over a period of approximately 5 y, sites were requested to submit a variety of phantoms, including uniform and American College of Radiology-approved phantoms, PET/CT images, and examples of clinical images. Submissions were divided into 3 distinct time periods: initial submission (T0) and 2 requalification submissions (T1 and T2). Images were analyzed using standardized procedures, and scanners received a pass or fail designation. Sites had the opportunity to submit new data for scanners that failed. Quantitative results were compared across scanners within a given time period and across time periods for a given scanner. Results: Data from 65 unique PET/CT scanners across 56 sites were submitted for CQIE T0 qualification; 64 scanners passed the qualification. Data from 44 (68%) of those 65 scanners were submitted for T2. From T0 to T2, the percentage of scanners passing the CQIE qualification on the first attempt rose from 38% for T1 to 67% for T2. The most common reasons for failure were SUV outside specifications, incomplete submission, and uniformity issues. Uniform phantom and American College of Radiology-approved phantom results between scanner manufacturers were similar. Conclusion: The results of the CQIE process showed that periodic requalification may decrease the frequency of deficient data submissions. The CQIE project also highlighted the concern within imaging facilities about the burden of maintaining different qualifications and accreditations. Finally, for quantitative imaging-based trials, further evaluation of the relationships between the level of the qualification (e.g., bias or precision) and the quality of the image data, accrual rates, and study power is needed.

Keywords: CQIE; PET qualification; quantitative imaging.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Image of 1 of 7 adjacent ROIs in liver regions used in body test cases.
FIGURE 2.
FIGURE 2.
(Left) Typical ROI used for uniformity analysis. (Right) Example of typical plot of mean SUVs per plane in ROI and calculation of maximum (max.) axial deviation (dev.) (MAD).
FIGURE 3.
FIGURE 3.
Image of ACR-approved PET phantom. Red ROIs are used for SUVmax, and blue ROIs are used for SUVpeak. Also shown are large background ROI (purple) and smaller green ROIs for cold cylinders. Latter ROIs were not used in this analysis.
FIGURE 4.
FIGURE 4.
Recovery coefficients (defined as ratio of measured SUV to true SUV) as function of cylinder diameters for static brain (A) and body (B) acquisitions.

References

    1. Pantel AR, Mankoff DA. Molecular imaging to guide systemic cancer therapy: illustrative examples of PET imaging cancer biomarkers. Cancer Lett. 2017;387:25–31. - PMC - PubMed
    1. Bengtsson T, Hicks RJ, Peterson A, Port RE. 18F-FDG PET as a surrogate biomarker in non–small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value. J Nucl Med. 2012;53:530–537. - PubMed
    1. Cornelis F, Storchios V, Violari E, et al. 18F-FDG PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation. J Nucl Med. 2016;57:1052–1057. - PMC - PubMed
    1. Humbert O, Riedinger JM, Charon-Barra C, et al. Identification of biomarkers including 18FDG-PET/CT for early prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer. Clin Cancer Res. 2015;21:5460–5468. - PubMed
    1. Kim JW, Oh JS, Roh JL, et al. Prognostic significance of standardized uptake value and metabolic tumour volume on 18F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2015;42:1353–1361. - PubMed

Publication types

MeSH terms

LinkOut - more resources